Genomics BioSci & Tech. Statistics
Total Valuation
TPEX:4195 has a market cap or net worth of TWD 1.95 billion. The enterprise value is 2.44 billion.
Market Cap | 1.95B |
Enterprise Value | 2.44B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
Earnings Date | Nov 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPEX:4195 has 72.45 million shares outstanding. The number of shares has increased by 0.02% in one year.
Current Share Class | 72.45M |
Shares Outstanding | 72.45M |
Shares Change (YoY) | +0.02% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 9.96% |
Owned by Institutions (%) | 4.60% |
Float | 53.19M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 3.45 |
PB Ratio | 3.24 |
P/TBV Ratio | 3.75 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -13.66 |
EV / Sales | 4.33 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -9.39 |
Financial Position
The company has a current ratio of 1.35, with a Debt / Equity ratio of 0.99.
Current Ratio | 1.35 |
Quick Ratio | 0.79 |
Debt / Equity | 0.99 |
Debt / EBITDA | n/a |
Debt / FCF | -2.28 |
Interest Coverage | -10.36 |
Financial Efficiency
Return on equity (ROE) is -28.95% and return on invested capital (ROIC) is -6.05%.
Return on Equity (ROE) | -28.95% |
Return on Assets (ROA) | -5.46% |
Return on Invested Capital (ROIC) | -6.05% |
Return on Capital Employed (ROCE) | -12.44% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.43 |
Inventory Turnover | 2.80 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +47.25% in the last 52 weeks. The beta is 0.19, so TPEX:4195's price volatility has been lower than the market average.
Beta (5Y) | 0.19 |
52-Week Price Change | +47.25% |
50-Day Moving Average | 21.55 |
200-Day Moving Average | 19.23 |
Relative Strength Index (RSI) | 65.95 |
Average Volume (20 Days) | 826,971 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4195 had revenue of TWD 563.09 million and -178.49 million in losses. Loss per share was -2.46.
Revenue | 563.09M |
Gross Profit | 163.10M |
Operating Income | -115.33M |
Pretax Income | -202.74M |
Net Income | -178.49M |
EBITDA | -57.70M |
EBIT | -115.33M |
Loss Per Share | -2.46 |
Balance Sheet
The company has 177.23 million in cash and 592.47 million in debt, giving a net cash position of -415.24 million or -5.73 per share.
Cash & Cash Equivalents | 177.23M |
Total Debt | 592.47M |
Net Cash | -415.24M |
Net Cash Per Share | -5.73 |
Equity (Book Value) | 601.23M |
Book Value Per Share | 7.23 |
Working Capital | 151.17M |
Cash Flow
In the last 12 months, operating cash flow was -140.25 million and capital expenditures -119.30 million, giving a free cash flow of -259.54 million.
Operating Cash Flow | -140.25M |
Capital Expenditures | -119.30M |
Free Cash Flow | -259.54M |
FCF Per Share | -3.58 |
Margins
Gross margin is 28.96%, with operating and profit margins of -20.48% and -31.70%.
Gross Margin | 28.96% |
Operating Margin | -20.48% |
Pretax Margin | -36.01% |
Profit Margin | -31.70% |
EBITDA Margin | -10.25% |
EBIT Margin | -20.48% |
FCF Margin | n/a |
Dividends & Yields
TPEX:4195 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.02% |
Shareholder Yield | n/a |
Earnings Yield | -9.18% |
FCF Yield | -13.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on August 8, 2023. It was a forward split with a ratio of 1.02.
Last Split Date | Aug 8, 2023 |
Split Type | Forward |
Split Ratio | 1.02 |
Scores
TPEX:4195 has an Altman Z-Score of 1.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.13 |
Piotroski F-Score | 2 |